Rocket One Inc.

RKTO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017
Revenue
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $785.3K
SG&A Expense
Operating Income $-2.5M
Operating Margin
Interest Expense
Pretax Income
Income Tax Expense
Net Income $-2.5M
Net Margin
EPS (Basic) $-0.08
EPS (Diluted) $-0.08
Shares Outstanding (Basic) 30.4M 28.2M
Shares Outstanding (Diluted) 30.4M 28.2M
Dividends Per Share
← Newer Page 2 of 2 Older →